1.68

13.51% 0.20

After Hours: 1.62 -0.06 -3.57%

Marker Therapeutics Inc (MRKR)

Overview News Price History Financials Discussions Forecast Stock Split

Marker Therapeutics Inc stock is traded at $1.68, with a volume of 227.99K. It is up +13.51% in the last 24 hours and up +18.31% over the past month. Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Previous Close:

$1.48

Open:

$1.48

24h Volume:

227.99K

Relative Volume:

2.56

Market Cap:

$28.01M

Revenue:

$3.20M

Net Income/Loss:

$-10.90M

P/E Ratio:

-2.4933

EPS:

-0.6738

Net Cash Flow:

$-7.92M

1W Performance:

+14.29%

1M Performance:

+18.31%

6M Performance:

-23.29%

1Y Performance:

+7.01%

1-Day Range:

$1.48

$1.72

1-Week Range:

$1.4414

$1.72

52-Week Range:

$0.8099

$4.07

Marker Therapeutics Inc Stock (MRKR) Company Profile

Name

Marker Therapeutics Inc

Sector

Healthcare (1094)

Industry

Biotechnology (615)

Phone

(713) 400-6400

Address

2450 HOLCOMBE BLVD, HOUSTON, TX

Employee

Twitter

@MRKRTherapeutic

Next Earnings Date

2026-08-13

Latest SEC Filings

MRKR's Discussions on Twitter

Compare MRKR vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRKR Marker Therapeutics Inc	1.68	24.68M	3.20M	-10.90M	-7.92M	-0.6738
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-05-25	Initiated	Canaccord Genuity	Buy
Mar-25-21	Initiated	Piper Sandler	Overweight
Mar-19-21	Initiated	Cantor Fitzgerald	Overweight
May-12-20	Downgrade	Piper Sandler	Overweight → Neutral
May-30-19	Initiated	ROTH Capital	Buy
Mar-01-19	Initiated	Janney	Buy
Dec-03-18	Upgrade	Piper Jaffray	Neutral → Overweight

View All

Marker Therapeutics Inc Stock (MRKR) Latest News

12:49 PM

MSN Money - MSN

12:49 PM

Jul 02, 2026

Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Profit Outlook - simplywall.st

Jul 02, 2026

Jul 01, 2026

MRKR Q1 2026 Earnings: Narrower Loss Surpasses ExpectationsRevenue Growth Outlook - dars.gov.et

Jul 01, 2026

Jun 30, 2026

US High Growth Tech Stocks to Watch - simplywall.st

Jun 30, 2026

Jun 27, 2026

Stock List: Research Stocks from Around the World - GuruFocus

Jun 27, 2026

Jun 26, 2026

Price to earnings forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView

Jun 26, 2026

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Jun 26, 2026